ZikaPlan

ZikaPlan
Name	ZikaPlan
Formation	2016
Type	Research consortium
Region served	Latin America, Africa, Europe

ZikaPlan was an international research consortium formed in response to the 2015–2016 outbreak of Zika virus disease. It coordinated multidisciplinary research on Aedes aegypti, maternal health, congenital infections, and public health preparedness across partners in Brazil, Colombia, Peru, Panama, Guatemala, Mexico, United Kingdom, Germany, France, and Spain. The initiative linked academic institutions, public health agencies, and non-governmental organizations to accelerate evidence generation relevant to clinical management, vector control, and surveillance during the epidemic involving World Health Organization emergency declarations and regional responses by Pan American Health Organization.

Overview

ZikaPlan assembled specialists in virology, epidemiology, obstetrics and gynecology, neurology, and entomology to investigate Zika-associated outcomes such as congenital Zika syndrome, microcephaly clusters first noted in Pernambuco, and neurological complications akin to Guillain–Barré syndrome. It operated alongside contemporaneous programmes like Zika Active Project, ZIKAlliance, and national response efforts within Brazilian Ministry of Health and Instituto Oswaldo Cruz. The consortium emphasized rapid data sharing, standardized protocols, and links with surveillance systems used by institutions such as London School of Hygiene & Tropical Medicine, National Institutes of Health, Institut Pasteur, and Fiocruz.

Objectives and Scope

Primary objectives included generating clinical case definitions for congenital infection, refining diagnostic algorithms connecting RT-PCR and serology platforms such as tests developed by Centers for Disease Control and Prevention and Public Health England, and evaluating vector control strategies informed by studies on Aedes albopictus and Aedes aegypti ecology. Scope spanned cohort studies of pregnant people in urban and peri-urban settings, laboratory investigations of viral neurotropism in models referenced by work at Max Planck Institute for Infection Biology and Walter Reed Army Institute of Research, and health systems research drawing on comparative frameworks from British Columbia Centre for Disease Control and Imperial College London modelling teams. Secondary aims addressed communication strategies used in responses by Médecins Sans Frontières and community engagement approaches utilized in programs backed by Bill & Melinda Gates Foundation.

Consortium and Partners

ZikaPlan convened universities, public research institutes, and NGOs including partner sites in São Paulo University, Federal University of Pernambuco, Universidad de Antioquia, University of Oxford, Karolinska Institute, Institut Pasteur de Paris, and Universidad Nacional Autónoma de México. Collaborators included surveillance agencies such as Agência Nacional de Vigilância Sanitária, national reference laboratories like Brazilian National Institute of Infectious Diseases, and philanthropic research funders linked to Wellcome Trust and European Commission. Operational partners ranged from clinical hospitals (for example, Hospital das Clínicas de São Paulo) to community organizations exemplified by local maternal health networks active in Recife, Barranquilla, and Lima.

Methodology and Activities

Research methods combined prospective cohort designs, case-control investigations, entomological surveys, and laboratory virology. Clinical cohorts enrolled pregnant persons and neonates following protocols harmonized with consortia such as ZIKAlliance and utilized imaging standards popularized at Great Ormond Street Hospital and Johns Hopkins Hospital for cranial ultrasound, magnetic resonance imaging, and neurodevelopmental follow-up. Diagnostics integrated molecular assays originally validated by Centers for Disease Control and Prevention and serological platforms with confirmatory neutralization tests referencing methods from World Reference Center for Emerging Viruses and Arboviruses. Entomological activities applied marking-release-recapture methods comparable to studies at James Cook University and assessed insecticide resistance with guidance from London School of Hygiene & Tropical Medicine investigators. Data management used common data elements aligning with standards promoted by European Centre for Disease Prevention and Control and analytic techniques drew from modelling approaches used in outbreak analyses at Imperial College London and Los Alamos National Laboratory.

Outcomes and Impact

ZikaPlan produced harmonized clinical definitions for congenital infection adopted by regional networks and contributed peer-reviewed findings to journals where research from Instituto Butantan and University of São Paulo also appeared. Outputs included upgraded surveillance case classifications used by Pan American Health Organization member states, improved laboratory algorithms for distinguishing cross-reactive flavivirus serology in regions endemic for dengue virus, and entomological risk maps informing vector control strategies also referenced by programmes in Florida and Puerto Rico. The consortium’s neurodevelopmental follow-up studies influenced clinical guidelines in referral centres like Hospital Nacional Arzobispo Loayza and informed policy dialogues in ministries of health across affected countries. Capacity-building efforts advanced laboratory skills at national reference centers mirroring investments seen at Oswaldo Cruz Foundation and strengthened collaborative networks that persisted beyond the epidemic.

Funding and Governance

Funding combined competitive grants from international research funders such as the European Commission research programmes and philanthropic awards connected to Wellcome Trust and foundations active in global health. Governance employed a steering committee structure with representation from participating academic partners and national reference laboratories, similar to governance models used by ZIKAlliance and Ebola Ça Suffit! trial consortia. Ethical oversight involved institutional review boards at partner universities including University of Oxford Ethics Committee and national ethical bodies in Brazil and Colombia, ensuring alignment with research regulations and participant protections championed by entities like Council for International Organizations of Medical Sciences.

Category:Medical research consortia